Summit Therapeutics Inc. (SMMT): Operating Income

Annual figures by period end, from SEC filings.

-$226.00M
Year ended 2024-12-31
$5.39M2019-01-31: $5.39M2020-12-31: -$53.19M2021-12-31: -$86.19M2022-12-31: -$72.09M2023-12-31: -$609.65M2024-12-31: -$226.00M-$226.00M
2019-01-31 Operating Income (USD) 2024-12-31
Period endedOperating IncomeChange YoYSource filing
2024-12-31-$226.00Mn/m2025-02-24, From 2024-01-01
2023-12-31-$609.65Mn/m2025-02-24, From 2023-01-01
2022-12-31-$72.09Mn/m2025-02-24, From 2022-01-01
2021-12-31-$86.19Mn/m2023-03-09, From 2021-01-01
2020-12-31-$53.19Mn/a2022-12-21, From 2020-01-01
No annual figure between 2019-01-31 and 2020-12-31.
2019-01-31$5.39Mn/a2021-03-31, From 2018-02-01